SLC16A3 and atherosclerosis: Genetic deletion of MCT4 from inflammatory macrophages increases intracellular lactate levels, enhances H3K18 lactylation, and promotes expression of reparative M2 and TCA cycle genes, thereby shifting the macrophage phenotype toward inflammation resolution and reducing atherosclerosis (i.e., M2) [32].